US3521637A - Tampon or similar sanitary napkin containing vitamin a - Google Patents
Tampon or similar sanitary napkin containing vitamin a Download PDFInfo
- Publication number
- US3521637A US3521637A US686021A US3521637DA US3521637A US 3521637 A US3521637 A US 3521637A US 686021 A US686021 A US 686021A US 3521637D A US3521637D A US 3521637DA US 3521637 A US3521637 A US 3521637A
- Authority
- US
- United States
- Prior art keywords
- vitamin
- tampon
- present
- vaginal
- rupturable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940045997 vitamin a Drugs 0.000 title description 67
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 66
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 66
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 66
- 235000019155 vitamin A Nutrition 0.000 description 66
- 239000011719 vitamin A Substances 0.000 description 66
- 239000002775 capsule Substances 0.000 description 30
- 239000011159 matrix material Substances 0.000 description 30
- 239000012528 membrane Substances 0.000 description 20
- 239000000463 material Substances 0.000 description 16
- 210000001215 vagina Anatomy 0.000 description 13
- 229920002678 cellulose Polymers 0.000 description 12
- 235000010980 cellulose Nutrition 0.000 description 12
- -1 tricarboxylic acid esters Chemical class 0.000 description 12
- 239000001913 cellulose Substances 0.000 description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 208000035475 disorder Diseases 0.000 description 11
- 230000002745 absorbent Effects 0.000 description 10
- 239000002250 absorbent Substances 0.000 description 10
- 239000000835 fiber Substances 0.000 description 9
- 210000003905 vulva Anatomy 0.000 description 9
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 210000004914 menses Anatomy 0.000 description 8
- 230000035935 pregnancy Effects 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 7
- 239000003094 microcapsule Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 210000003097 mucus Anatomy 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010046914 Vaginal infection Diseases 0.000 description 3
- 201000008100 Vaginitis Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000002480 mineral oil Substances 0.000 description 3
- 235000010446 mineral oil Nutrition 0.000 description 3
- 239000000123 paper Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229930185605 Bisphenol Natural products 0.000 description 2
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229940035811 conjugated estrogen Drugs 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000001076 estrogenic effect Effects 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000003780 keratinization Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 206010003693 Atrophic vulvovaginitis Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 208000001126 Keratosis Diseases 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- 108091007643 Phosphate carriers Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940111121 antirheumatic drug quinolines Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000011111 cardboard Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229940059082 douche Drugs 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229940106582 estrogenic substances Drugs 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000002791 naphthoquinones Chemical class 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 239000002530 phenolic antioxidant Substances 0.000 description 1
- 125000001476 phosphono group Chemical group [H]OP(*)(=O)O[H] 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 201000010808 postmenopausal atrophic vaginitis Diseases 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 150000003248 quinolines Chemical class 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 239000012209 synthetic fiber Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/34—Means for withdrawing tampons, e.g. withdrawal strings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
- A61F13/2051—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the material or the structure of the inner absorbing core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
Definitions
- a tampon or similar sanitary napkin containing vitamin A either microencapsulated within the fibrous matrix of the tampon or enclosed within one or more rupturable membranes or capsules within the tampon matrix, such rupturable membranes or capsules being broken by the exertion of slight finger pressure or mechanical opening before insertion of the tampon or similar article.
- the microencapsulated vitamin A is also released by slight finger pressure, or by the heat of the body adjacent the vaginal tampon, sanitary napkin, etc.
- the present invention relates to new and improved tampons and sanitary napkins or similar articles and more particularly to such tampons, sanitary or similar articles which contain a minor amount of vitamin A microencap- 'sulated throughout the fibrous matrix of the article or encapsulated within one or more rupturable membranes or capsules within the matrix of the tampon or similar article.
- vaginitis a condition which develops more easily in some women than others, and which is frequently associated with their monthly discharge period.
- vaginitis a condition which develops more easily in some women than others, and which is frequently associated with their monthly discharge period.
- the danger of infection increases during this time because foreign microorganisms or other outside sources of infection may be introduced through careless handling of sanitary napkins, or more especially, through careless handling and insertion of absorbent tampons.
- vaginal area is also disrupted during the time of pregnancy.
- the vaginal area at this time is similarly subject to various disorders such as vaginitis.
- Other disorders of the vagina and vulva which can occur during the menses and during pregnancy include for example, abnormal senile vaginitis, keratosis, dyskeratosis, hyperkeratinization and comification of the vagina and vulva.
- vaginal tampon, sanitary napkin, or similar device in accordance with the present invention also, in providing a ready method for the administration of vitamin A, allows for the regeneration of cornified vaginal epithelium.
- FIG. 1 is a perspective view of a conventional vaginal tampon
- FIG. 2 is a cross-sectional view of the vaginal tampon of FIG. 1 taken along line 22 showing one embodiment of the present invention
- FIG. 3 is a modified cross-sectional view of the tampon of FIG. 1 taken along line 22 showing a further embodiment of the present invention.
- FIG. 4 is a further modified cross-sectional view of the vaginal tampon of FIG. 1 taken along line 2r-2 showing a further embodiment of the present invention.
- FIG. 5 is a further modified cross-sectional view of the vaginal tampon of FIG. 1 taken along line 22 showing a further embodiment of the present invention.
- FIG. 1 shows a conventional vaginal tampon 1.
- FIG. 2 shows a vaginal tampon 1 containing a conven tional cellulosic or paper wrapper 3 and a fibrous matrix 5 in accordance with one embodiment of the present invention.
- Vaginal tampons suitable for use in this invention are usually made of absorbent fibers, including natural and synthetic fibers, compressed into a unitary body of a size which may easily be inserted into the vaginal cavity. They are normally made in an elongated cylindrical form in order that they may have a sufiiciently large body of material to provide the required absorbing capacity, but may be made in a variety of shapes.
- the tampon may or may not be compressed, although compressed types are now generally preferred.
- the tampon described in U.S. Pat. No. 2,761,449, dated Sept. 4, 1956, is typical. This patent shows a tampon made of various fiber blends including both absorbent and nonabsorbent fibers, which may or may not have a suitable jacket or wrapper.
- the fibrous matrix ordinarily used to make absorbent products are usually cellulosic.
- These cellulosic materials may be chemically modified to form cellulosic derivatives which have acidifying properties and at the same time retain essentially their original fibrous characteristics, thus permitting their use in absorbent products requiring a fibrous form and requiring the absorbent capacities obtainable with such fibers.
- the fibers are usually modified so that they are essentially water insoluble so that they retain their fibrous form in order that they may be withdrawn from the vagina after use.
- modified cellulosic materials include cellulose acid succinate, cellulose acid maleate and cellulose acid malonate; tricarboxylic acid esters, such as cellulose acid citrate; mineral acid esters, such as cellulose acid sulphate, phosphorylated cellulose and sulfonated cellulose; cellulose acid ethers, such as carboxymethyl cellulose, carboxyethyl cellulose; cellulose anhydrides, such as cellulose carboxymethyl anhydride; alkyl sulfonic acid ethers, such as sulfoethyl cellulose; phosphono alkylated celluloses; and mixtures thereof.
- cellulose acid succinate such as cellulose acid maleate and cellulose acid malonate
- tricarboxylic acid esters such as cellulose acid citrate
- mineral acid esters such as cellulose acid sulphate, phosphorylated cellulose and sulfonated cellulose
- cellulose acid ethers such as carboxymethyl cellulose, carboxyethyl
- the vaginal tampon 1 may contain a string 7 of any suitable material to assist in withdrawal of the tampon 1 after use. Additionally, the vaginal tampon 1 may have associated therewith a conventional insertion device, not shown.
- a rupturable membrane 9 containing vitamin A 11 is included within the fibrous matrix 5 .
- vitamin A does not form a true solution in water it does form a colloidal suspension closely resembling a true solu tion and thus such a system can be advantageously employed within the rupturable capsules.
- a solution of vitamin A is shown in US. Pat. 2,417,291 and according by the term aqueous solution as employed throughout this application is meant to embrace such a system.
- the rupturable capsule 9, in accordance with this embodiment of the present invention, can be formed of an easily rupturable material which can be ruptured by the exertion of slight mechanical pressure exerted by pulling string 13.
- Suitable materials include, for example, gelatin, egg white, various synthetic resins, such as polyethylene, polypropylene, etc.
- the beneficial vitamin A is dispersed in the fibrous matrix by pulling string 13 extending from the tampon immediately before insertion. In this manner, the rupturable membrane breaks and the vitamin A is dispersed in liquid form in the fibrous matrix so that it can be easily and readily administered to the areas of the vagina and vulva to be treated. While FIG. 2 shows a large rupturable capsule 9 within the conventional tampon 1, it should be clear that this embodiment of the present invention also contemplates two or more rupturable capsules within the fibrous matrix 5.
- FIG. 2 illustrates an alternative embodiment wherein an end wall 15 containing perforations 17 is provided adjacent the rupturable capsule 9.
- the end wall 15 can be made of any suitable paper, cardboard or plastic material.
- the perforations 17 allow passage of string 13 and vitamin A when released from the capsule 9.
- the end wall 15 prevents movement of the capsule 9 when string 13 is pulled before insertion.
- tampon 1 allows for a method of administering or distributing vitamin A to the vaginal area of the female body so as to prevent or treat those disorders associated with menses, pregnancy, etc.
- disorders include vaginitis and other disorders relating to the keratinization of the mucus membranes, of the vaginal area.
- the vitamin A acts to prevent or treat such disorders of the vaginal area by revers ing the keratinization of the mucus membranes.
- the vitamin A tends to regenerate abnormal cornified vaginal epithelium tissue when applied as in accordance with the present invention.
- vaginal tampons generally range in weight from about 1.8 to about 3 grams. Although they are capable of absorbing from about 5 ml. of fluid in the lower part of the range to about 10 ml. of fluid in the upper part of the range, they are ordinarily discarded before they become saturated and usually when they have absorbed about one half of the amounts of menstrual fluid they are capable of absorbing, e.g., from about 2.5 to about 5 ml.
- the amount of vitamin A to be incorporated in such a conventional tampon comprises only that amount necessary to be absorbed into the vaginal area so as to create the beneficial effect associated with the intake of vitamin A. Generally such amount ranges from about 0.01% to about 10% by weight of the tampon article, although lesser or greater amounts can be advantageously employed Where desired.
- FIG. 3 illustrates a modified form of the tampon in accordance with the present invention.
- the tampon 1 shown in FIG. 3 again comprises a wrapper 3 having therein a fibrous matrix 5.
- Incorporated within the fibrous matrix 5 are two rupturable membranes or capsules 9 containing vitamin A 11 either alone or in aqueous or other suitable systems, e.g., mineral oil. While two rupturable capsules 9 are shown in this embodiment of the present invention, it is of course, obvious that a single capsule can be utilized, or alternatively, a multiplicity of smaller capsules can be suitably employed.
- the rupturable capsules 9 in accordance with this embodiment of the present invention can again be formed of any easily rupturable material which is capable of being ruptured by the exertion of slight pressure applied by pressing the fingers against the outer wrapper 3 prior to insertion of the tampon or similar device.
- the rupturable capsule or membrane 9 can be formed of the same orv similar materials as previously set forth for the rupturable capsule shown in FIG. 2 which rupturable capsule is ruptured by the exertion of mechanical pressure by the pulling of the string attached to the membrane or capsule.
- the beneficial vitamin A is dispersed within the fibrous matrix by squeezing the tampon immediately before insertion. In this manner, the rupturable membrane, or capsule breaks and the vitamin A is dispersed in liquid form within the fibrous matrix so that it can be easily and readily administered to the areas of the vagina and vulva to be treated.
- rupturable capsules or membranes 9 as shown in FIG. 3 are located near one end of the tampon or similar device, it is of course, obvious that one or more rupturable capsules or membranes 9 can be located anywhere within the tampon body. In this respect, some outer marking, e.g., coloration on the wrapper of the tampon can be used to indicate at what point slight pressure should be exerted so as to effect the rupturing of the capsules or membranes 9 so as to release the beneficial vitamin A.
- the vitamin A need only be employed in that amount necessary to supply its beneficial affect to the vagina, vulva and related areas so as to prevent or treat those disorders associated with menses, pregnancy, etc.
- an amount of from 0.01 to about 10% by weight of the tampon or similar article is generally effective for this purpose although lesser or greater amounts can be employed where desired.
- FIG. 4 A further embodiment of the present invention is illustrated in FIG. 4.
- This embodiment again shows a conventional tampon 1 having an outer paper or cellulosic wrapper 3 and an inner cellulosic matrix 5.
- Within the cellulosic matrix 5 of the tampon 1 are located tiny microencapsulated droplets or aerosol 19 of vitamin A.
- this embodiment of the invention utilizes tiny microencapsulated droplets of vitamin A in lieu of one or more larger rupturable membranes or capsules located within the matrix of the tampon 1.
- These tiny microencapsulated droplets of vitamin A located within the matrix 5 of the tampon 1 are susceptible to rupturing by the exertion of slight pressure and thus, as was the case with the embodiment shown in FIG.
- the tiny encapsulated droplets of vitamin A can be uniformly or randomly dispersed throughout the matrix 5 of the tampon 1. If the encapsulated vitamin A is located in one portion of the tampon, it is preferable that the outer wrapper 3 be marked as by coloration so as to indicate at what portion the slight pressure should be exerted so as to release the valuable vitamin A.
- the amount of vitamin A that is included within the microcapsules is that same amount as set forth above with respect to the employment of the larger rupturable capsules of FIGS. 2 and 3.
- a suitable system can comprise powdered vitamin A in a conventional phosphate carrier.
- FIG. 5 A further embodiment of the present invention is shown in FIG. 5.
- the vitamin A is present in the microcapsules 21 within the outer wrapper'3 of the tampon 1.
- the microcapsules 21 of vitamin A can be ruptured merely by the heat of the body adjacent the vaginal tampon.
- the amount of vitamin A employed is as set forth above. Again, a solid vitamin A system can be suitably utilized.
- this embodiment illustrates the microcapsules of vitamin A within the outer wrapper 3 of the tampon
- the same effect of rupturing by body heat can be achieved by incorporating the microcapsules of vitamin A in the fibrous matrix close to the outer portion thereof.
- FIGS. 1 through 5 illustrate the employment of vitamin A in accordance with the present invention in a conventional vaginal tampon
- vitamin A in combination with an extremely worn sanitary napkin.
- the vitamin A is incorporated within the matrix of the napkin either as tiny droplets or in a rupturable capsule, such vitamin A can have its therapeutic value when a napkin is in contact with the external genitalia.
- This is extremely useful in cases Where the external genitalia are easily irritated or subject to minor infections.
- the vitamin A can be absorbed into the mucus membranes of the vagina and vulva as is capable with the employment of a vaginal tampon.
- the tampon or similar article therefore acts as a douche in its administration of vitamin A, etc.
- the present invention has been described primarily to the employment of vitamin A in a vaginal tampon, sanitary napkin, or similar article, it should be understood that the present invention can also include the incorporation of other vitamins, minerals and nutrients, alone or in combination with vitamin A, which can be administered to the mucus membranes of the vagina area. Additionally, other ingredients, such as antioxidants, stabilizers, surface active agents, deodorants, etc., can be conventionally employed in the tampon, sanitary napkin or similar article in accordance with the present invention. In this respect, it is sometimes advantageous to employ a stabilizer in conjunction with vitamin A so as to stabilize such material against unwanted deterioration before use.
- Suitable stabilizing agents or; antioxidants which can be employed in accordance with the present invention include, for example, the phenolic antioxidants, e.g., alkyl phenols, alkyl bisphenols, bisphenol sulfides, quinones, such as hydroquinone, antraquinone, naphthaquinone and substituted derivatives thereof and heterocylic compounds such as pyridines, piperidienes, quinolines, etc.
- a particularly preferred stabilizer for vitamin A comprises ethoxyquin-l,2-dehydro-6-ethoxy- 2,2,4-trimethyl quinoline sold by Monsanto Chemical Company under the trademark Santoquin.”
- a particularly advantageous combination of ingredients comprises vitamin A in combination with an estrogenic substance.
- a suitable system to be employed in accordance with the present invention comprises vitamin A and a material such as estradiol, estrone or the conjugated estrogens produced from the urine of pregnant mares. Because of the water solubility of such conjugated estrogens, such estrogenic substances can be conveniently employed in the water solution of vitamin A, preferably employed in accordance with the present invention.
- the estrogenic material if employed in combination with vitamin A in accordance with the present invention, tends to promote the beneficial effect of the vitamin A.
- the employment of the estrogenic material is beneficial in helping to supply the physiological balance of hormones produced by the normal ovary.
- This material is generally employed in approximately equal amounts with the vitamin A present within the sanitary napkin, vaginal tampon, etc.
- the present invention therefore, provides a new and novel tampon, sanitary napkin, or similar article containing a minor amount of vitamin A.
- the present invention also, however, comprises a method of administering vitamin A and other vitamins, minerals and nutrients to the vaginal area so as to prevent or treat various disorders associated with menses, pregnancy, etc.
- the articles of the present invention wherein the vitamin A is microencapsulated or included within one or more rupturable capsules or membranes, provide a great improvement over the mere inclusion of a valuable substance within the matrix of a tampon or similar article.
- the vitamin A is protected until use from any harmful effects associated with heat, light or other atmospheric conditions.
- a compressed vaginal tampon or sanitary napkin adapted to be inserted within or applied adjacent to the vaginal cavity under normal conditions of use and capable of increasing the integrity of the epithelial lining of the vaginal cavity, said compressed vaginal tampon or sanitary napkin comprising an outer wrapper and a matrix of compressed absorbent fibers within said outer wrapper, and containing, dispersed in said matrix of compressed absorbent fibers or outer wrapper, a minor amount of vitamin A encapsulated alone or in the form of an aqueous or mineral oil solution of the active vitamin.
- a compressed vaginal tampon or sanitary nap-kin adapted to be inserted within or applied adjacent to the vaginal cavity under normal conditions of use and capable V 8 of increasing the integrity of the epithelial lining of the 3,091,241 5/1963 Kellett 424-28 vaginal cavity, said compressed vaginal tampon or sani- 3,137,631 6/1964 Soloway 42428 tary napkin comprising an outer Wrapper and a matrix of compressed absorbent fibers within said outer wrapper, FOREIGN and containing, dispersed in said matrix of compressed 5 735,370 3/ 9 Great Britainabsorbent fibers or outer Wrapper, a minor amount of 765,457 1957 Great Brltaln.
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Reproductive Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Absorbent Articles And Supports Therefor (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US68602167A | 1967-11-28 | 1967-11-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3521637A true US3521637A (en) | 1970-07-28 |
Family
ID=24754580
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US686021A Expired - Lifetime US3521637A (en) | 1967-11-28 | 1967-11-28 | Tampon or similar sanitary napkin containing vitamin a |
Country Status (12)
Cited By (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636922A (en) * | 1970-02-19 | 1972-01-25 | David C Ketner | Fluid applicators |
US3691154A (en) * | 1970-05-05 | 1972-09-12 | Kimberly Clark Co | Absorbent fibers of phosphorylated cellulose with ion exchange properties |
US3850160A (en) * | 1973-02-15 | 1974-11-26 | J Denson | Diagnostic tampon and the use thereof for collecting cellular material |
US3918452A (en) * | 1974-08-01 | 1975-11-11 | Edward Cornfeld | Tampons impregnated with contraceptive compositions |
US3921636A (en) * | 1973-01-15 | 1975-11-25 | Alza Corp | Novel drug delivery device |
US4136697A (en) * | 1972-11-24 | 1979-01-30 | Avtex Fibers Inc. | Fibers of high fluid-holding capacity |
US4226232A (en) * | 1979-04-09 | 1980-10-07 | Spenco Medical Corporation | Wound dressing |
US4271835A (en) * | 1978-05-17 | 1981-06-09 | Kcdp Corporation | Fluid-expansible contraceptive tampon and applicator |
US4286596A (en) * | 1978-02-27 | 1981-09-01 | Herbert Rubinstein | Tampon containing a liquid medicant |
WO1982002489A1 (en) * | 1981-01-23 | 1982-08-05 | Corp Kcdp | Fluid expansible contraceptive tampon and applicator |
WO1982004185A1 (en) * | 1981-05-29 | 1982-12-09 | Corp Kcdp | Fluid-expansible contraceptive tampon and applicator |
US4439194A (en) * | 1981-09-08 | 1984-03-27 | Merck & Co., Inc. | Water and drug delivery system for suppository use |
US4553965A (en) * | 1978-05-17 | 1985-11-19 | Shepard Conn | Fluid-expansible contraceptive tampon and applicator |
US6558362B1 (en) | 1999-02-03 | 2003-05-06 | Bernard Chaffringeon | Disposable device for transferring an active liquid into a body cavity |
US20030153864A1 (en) * | 2001-10-16 | 2003-08-14 | Bernard Chaffringeon | Disposable device and method for transferring an active liquid into a body cavity |
US6758840B2 (en) | 2000-04-20 | 2004-07-06 | Metris Therapeutics Limited | Drug delivery device |
WO2005004837A1 (en) * | 2003-07-10 | 2005-01-20 | Galen (Chemicals) Limited | Intravaginal drug delivery devices |
US20050070491A1 (en) * | 1994-07-15 | 2005-03-31 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US20050111900A1 (en) * | 2004-11-30 | 2005-05-26 | Francesca Fazzolari | Ampoule and method of use |
US20060113318A1 (en) * | 2004-11-30 | 2006-06-01 | May Richard J | Dispenser and process |
US20060142722A1 (en) * | 2004-12-29 | 2006-06-29 | Kimberly-Clark Worldwide, Inc. | Multilayer absorbent article |
US20060185678A1 (en) * | 2005-02-03 | 2006-08-24 | Bronnenkant Lance J | Devices for delivering agents to a vaginal tract |
US20060216334A1 (en) * | 2005-03-25 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
US20060213918A1 (en) * | 2005-03-25 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Dosage cap assembly for an applicator |
US20060217652A1 (en) * | 2005-03-25 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Delivery tube assembly for an applicator |
US20060213919A1 (en) * | 2005-03-25 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Protective tube for a medicated tampon |
US20060218690A1 (en) * | 2005-04-01 | 2006-10-05 | James Leslie J | Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment |
US20060247571A1 (en) * | 2005-04-28 | 2006-11-02 | Hayes Rebecca D | Dosage form cap for an applicator |
US20070141118A1 (en) * | 2005-12-15 | 2007-06-21 | Damico Joyce A | Layered dosage form for a medicated tampon assembly |
US20070253761A1 (en) * | 2006-04-28 | 2007-11-01 | May Richard J | Multi-chambered dispenser and process |
US20090152295A1 (en) * | 2007-12-18 | 2009-06-18 | James Alexander Corporation | Container Assembly |
US20090152267A1 (en) * | 2007-12-18 | 2009-06-18 | James Alexander Corporation | Container Assembly |
US20090152296A1 (en) * | 2007-12-18 | 2009-06-18 | James Alexander Corporation | Container Assembly |
US20090196675A1 (en) * | 2008-01-29 | 2009-08-06 | James Alexander Corporation | Dispenser and process |
US20180098888A1 (en) * | 2016-10-07 | 2018-04-12 | Emily M. Gahr | Tampon Retainer |
US10118847B2 (en) * | 2017-04-11 | 2018-11-06 | Alexander B. Howe | Structures for the reduction of water impurities and methods for the deployment thereof |
EP3626230A1 (en) | 2014-05-15 | 2020-03-25 | Grünenthal GmbH | Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ |
USRE49139E1 (en) | 2015-04-16 | 2022-07-19 | Nguyenovation Incorporated | Swimming aid device |
US20230355448A1 (en) * | 2022-05-05 | 2023-11-09 | Tony Griffith | Feminine Hygiene Assembly |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2184498A1 (en) * | 1972-05-17 | 1973-12-28 | Lhd Lab Hygiene Dietetique | Surgical dressing impregnated with medicament - coated for protection against light, oxygen and damp |
DE3447833A1 (de) * | 1984-12-29 | 1986-07-10 | Allan Gerhard 8047 Karlsfeld Frühauf | Tuch o.dgl. mit einen wirkstoff enthaltenden mikrokapseln |
DE19713908A1 (de) * | 1997-04-04 | 1998-10-08 | Symbio Herborn Group Gmbh & Co | Vaginaltampon und Verfahren zu seiner Herstellung |
DE102016106354A1 (de) * | 2016-04-07 | 2017-10-12 | Hygiene Oederan Produktionsgesellschaft mbH | Verpackter Tampon |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2579403A (en) * | 1950-06-01 | 1951-12-18 | Slomowitz Julius | Medical bandage |
GB735370A (en) * | 1953-04-14 | 1955-08-17 | Edward Charles Edmund Hemsted | Improvements in and relating to fibrous materials, more especially for tampons and the like |
GB765457A (en) * | 1953-08-05 | 1957-01-09 | Edward Charles Edmund Hemsted | Improvements in and relating to the preparation of impregnated or medicated aggregates of water-soluble fibres and articles made therefrom |
US2841529A (en) * | 1952-08-29 | 1958-07-01 | Papeteries De La Robertsau Sa | Process for manufacturing cellulose wool and resulting products thereof |
US3091241A (en) * | 1959-08-26 | 1963-05-28 | Kimberly Clark Co | Vaginal tampon |
US3137631A (en) * | 1959-12-01 | 1964-06-16 | Faberge Inc | Encapsulation in natural products |
-
1967
- 1967-11-28 US US686021A patent/US3521637A/en not_active Expired - Lifetime
-
1968
- 1968-07-04 ES ES355744A patent/ES355744A1/es not_active Expired
- 1968-07-10 LU LU56460D patent/LU56460A1/xx unknown
- 1968-07-11 IT IT18844/68A patent/IT986755B/it active
- 1968-07-22 BE BE718403D patent/BE718403A/xx unknown
- 1968-09-05 AT AT864468A patent/AT285037B/de not_active IP Right Cessation
- 1968-10-23 NL NL6815147A patent/NL6815147A/xx unknown
- 1968-11-01 BR BR203675/68A patent/BR6803675D0/pt unknown
- 1968-11-04 IL IL31010A patent/IL31010A0/xx unknown
- 1968-11-08 DE DE19681807734 patent/DE1807734A1/de active Pending
- 1968-11-12 FR FR1594763D patent/FR1594763A/fr not_active Expired
- 1968-11-18 SE SE15655/68A patent/SE359735B/xx unknown
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2579403A (en) * | 1950-06-01 | 1951-12-18 | Slomowitz Julius | Medical bandage |
US2841529A (en) * | 1952-08-29 | 1958-07-01 | Papeteries De La Robertsau Sa | Process for manufacturing cellulose wool and resulting products thereof |
GB735370A (en) * | 1953-04-14 | 1955-08-17 | Edward Charles Edmund Hemsted | Improvements in and relating to fibrous materials, more especially for tampons and the like |
GB765457A (en) * | 1953-08-05 | 1957-01-09 | Edward Charles Edmund Hemsted | Improvements in and relating to the preparation of impregnated or medicated aggregates of water-soluble fibres and articles made therefrom |
US3091241A (en) * | 1959-08-26 | 1963-05-28 | Kimberly Clark Co | Vaginal tampon |
US3137631A (en) * | 1959-12-01 | 1964-06-16 | Faberge Inc | Encapsulation in natural products |
Cited By (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3636922A (en) * | 1970-02-19 | 1972-01-25 | David C Ketner | Fluid applicators |
US3691154A (en) * | 1970-05-05 | 1972-09-12 | Kimberly Clark Co | Absorbent fibers of phosphorylated cellulose with ion exchange properties |
US4136697A (en) * | 1972-11-24 | 1979-01-30 | Avtex Fibers Inc. | Fibers of high fluid-holding capacity |
US3921636A (en) * | 1973-01-15 | 1975-11-25 | Alza Corp | Novel drug delivery device |
US3850160A (en) * | 1973-02-15 | 1974-11-26 | J Denson | Diagnostic tampon and the use thereof for collecting cellular material |
US3918452A (en) * | 1974-08-01 | 1975-11-11 | Edward Cornfeld | Tampons impregnated with contraceptive compositions |
US4286596A (en) * | 1978-02-27 | 1981-09-01 | Herbert Rubinstein | Tampon containing a liquid medicant |
US4553965A (en) * | 1978-05-17 | 1985-11-19 | Shepard Conn | Fluid-expansible contraceptive tampon and applicator |
US4271835A (en) * | 1978-05-17 | 1981-06-09 | Kcdp Corporation | Fluid-expansible contraceptive tampon and applicator |
US4226232A (en) * | 1979-04-09 | 1980-10-07 | Spenco Medical Corporation | Wound dressing |
WO1982002489A1 (en) * | 1981-01-23 | 1982-08-05 | Corp Kcdp | Fluid expansible contraceptive tampon and applicator |
WO1982004185A1 (en) * | 1981-05-29 | 1982-12-09 | Corp Kcdp | Fluid-expansible contraceptive tampon and applicator |
US4439194A (en) * | 1981-09-08 | 1984-03-27 | Merck & Co., Inc. | Water and drug delivery system for suppository use |
US20050070491A1 (en) * | 1994-07-15 | 2005-03-31 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
US6558362B1 (en) | 1999-02-03 | 2003-05-06 | Bernard Chaffringeon | Disposable device for transferring an active liquid into a body cavity |
US20030191439A1 (en) * | 1999-02-03 | 2003-10-09 | Bernard Chaffringeon | Disposable device for transferring an active liquid into a body cavity |
US6758840B2 (en) | 2000-04-20 | 2004-07-06 | Metris Therapeutics Limited | Drug delivery device |
US20030153864A1 (en) * | 2001-10-16 | 2003-08-14 | Bernard Chaffringeon | Disposable device and method for transferring an active liquid into a body cavity |
US20070255232A1 (en) * | 2001-10-16 | 2007-11-01 | Bernard Chaffringeon | Disposable device and method for transferring an active liquid into a body cavity |
WO2005004837A1 (en) * | 2003-07-10 | 2005-01-20 | Galen (Chemicals) Limited | Intravaginal drug delivery devices |
US20070043332A1 (en) * | 2003-07-10 | 2007-02-22 | Galen (Chemiclas) Liimited | Intravaginal drug delivery devices |
US20070292195A1 (en) * | 2004-11-30 | 2007-12-20 | James Alexander Corporation | Dispenser and Process |
US20060113318A1 (en) * | 2004-11-30 | 2006-06-01 | May Richard J | Dispenser and process |
US7637679B2 (en) | 2004-11-30 | 2009-12-29 | James Alexander Corporation | Dispenser and process |
US20090255953A1 (en) * | 2004-11-30 | 2009-10-15 | James Alexander Corporation | Dispenser and process |
US7581899B2 (en) | 2004-11-30 | 2009-09-01 | James Alexander Corporation | Dispenser and process |
US20050111900A1 (en) * | 2004-11-30 | 2005-05-26 | Francesca Fazzolari | Ampoule and method of use |
US7833208B2 (en) * | 2004-12-29 | 2010-11-16 | Kimberly-Clark Worldwide, Inc. | Multilayer absorbent article |
US8353888B2 (en) | 2004-12-29 | 2013-01-15 | Kimberly-Clark Worldwide, Inc. | Multilayer absorbent article |
US20060142722A1 (en) * | 2004-12-29 | 2006-06-29 | Kimberly-Clark Worldwide, Inc. | Multilayer absorbent article |
US20110022016A1 (en) * | 2004-12-29 | 2011-01-27 | Kimberly-Clark Worldwide, Inc. | Multilayer absorbent article |
US20110022015A1 (en) * | 2004-12-29 | 2011-01-27 | Kimberly-Clark Worldwide, Inc. | Multilayer absorbent article |
US20060185678A1 (en) * | 2005-02-03 | 2006-08-24 | Bronnenkant Lance J | Devices for delivering agents to a vaginal tract |
US8388996B2 (en) | 2005-03-25 | 2013-03-05 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
US7744556B2 (en) | 2005-03-25 | 2010-06-29 | Kimberly-Clark Worldwide, Inc. | Delivery tube assembly for an applicator |
US7993667B2 (en) | 2005-03-25 | 2011-08-09 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
US7919453B2 (en) | 2005-03-25 | 2011-04-05 | Kimberly-Clark Worldwide, Inc. | Dosage cap assembly for an applicator |
US20060213919A1 (en) * | 2005-03-25 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Protective tube for a medicated tampon |
US20060217652A1 (en) * | 2005-03-25 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Delivery tube assembly for an applicator |
US20060213918A1 (en) * | 2005-03-25 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Dosage cap assembly for an applicator |
US20060216334A1 (en) * | 2005-03-25 | 2006-09-28 | Kimberly-Clark Worldwide, Inc. | Methods of manufacturing a medicated tampon assembly |
US7527614B2 (en) | 2005-03-25 | 2009-05-05 | Kimberly-Clark Worldwide, Inc. | Protective tube for a medicated tampon |
US20060218690A1 (en) * | 2005-04-01 | 2006-10-05 | James Leslie J | Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment |
US7708726B2 (en) | 2005-04-28 | 2010-05-04 | Kimberly-Clark Worldwide, Inc. | Dosage form cap for an applicator |
US20060247571A1 (en) * | 2005-04-28 | 2006-11-02 | Hayes Rebecca D | Dosage form cap for an applicator |
US20070141118A1 (en) * | 2005-12-15 | 2007-06-21 | Damico Joyce A | Layered dosage form for a medicated tampon assembly |
US20070253761A1 (en) * | 2006-04-28 | 2007-11-01 | May Richard J | Multi-chambered dispenser and process |
US8585308B2 (en) | 2006-04-28 | 2013-11-19 | James Alexander Corporation | Multi-chambered dispenser and process |
US7976234B2 (en) | 2006-04-28 | 2011-07-12 | James Alexander Corporation | Multi-chambered dispenser and process |
US10464719B2 (en) | 2006-04-28 | 2019-11-05 | James Alexander Corporation | Multi-chambered dispenser and process |
US20090152296A1 (en) * | 2007-12-18 | 2009-06-18 | James Alexander Corporation | Container Assembly |
US10017316B2 (en) | 2007-12-18 | 2018-07-10 | James Alexander Corporation | Container assembly |
US20090152295A1 (en) * | 2007-12-18 | 2009-06-18 | James Alexander Corporation | Container Assembly |
US8403178B2 (en) | 2007-12-18 | 2013-03-26 | James Alexander Corporation | Container assembly |
US20090152267A1 (en) * | 2007-12-18 | 2009-06-18 | James Alexander Corporation | Container Assembly |
US8910830B2 (en) | 2007-12-18 | 2014-12-16 | James Alexander Corporation | Container assembly |
US8100294B2 (en) | 2007-12-18 | 2012-01-24 | James Alexander Corporation | Container assembly |
US10392163B2 (en) | 2008-01-29 | 2019-08-27 | James Alexander Corporation | Dispenser and process |
US20090196675A1 (en) * | 2008-01-29 | 2009-08-06 | James Alexander Corporation | Dispenser and process |
US11034486B2 (en) | 2008-01-29 | 2021-06-15 | James Alexander Corporation | Dispenser and process |
EP3626230A1 (en) | 2014-05-15 | 2020-03-25 | Grünenthal GmbH | Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ |
US10765848B2 (en) | 2014-05-15 | 2020-09-08 | Gruenenthal Gmbh | Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ |
USRE49139E1 (en) | 2015-04-16 | 2022-07-19 | Nguyenovation Incorporated | Swimming aid device |
US20180098888A1 (en) * | 2016-10-07 | 2018-04-12 | Emily M. Gahr | Tampon Retainer |
US10702422B2 (en) * | 2016-10-07 | 2020-07-07 | Vlaar Innovations B.V. | Tampon retainer |
US10118847B2 (en) * | 2017-04-11 | 2018-11-06 | Alexander B. Howe | Structures for the reduction of water impurities and methods for the deployment thereof |
US20230355448A1 (en) * | 2022-05-05 | 2023-11-09 | Tony Griffith | Feminine Hygiene Assembly |
Also Published As
Publication number | Publication date |
---|---|
NL6815147A (enrdf_load_stackoverflow) | 1969-05-30 |
LU56460A1 (enrdf_load_stackoverflow) | 1968-10-24 |
FR1594763A (enrdf_load_stackoverflow) | 1970-06-08 |
DE1807734A1 (de) | 1969-08-14 |
IL31010A0 (en) | 1969-01-29 |
BR6803675D0 (pt) | 1973-03-07 |
SE359735B (enrdf_load_stackoverflow) | 1973-09-10 |
IT986755B (it) | 1975-01-30 |
BE718403A (enrdf_load_stackoverflow) | 1968-12-31 |
ES355744A1 (es) | 1970-10-16 |
AT285037B (de) | 1970-10-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3521637A (en) | Tampon or similar sanitary napkin containing vitamin a | |
US3905372A (en) | Feminine hygiene protective shield | |
US3490454A (en) | Catamenial products having a coating of rupturable microcapsules containing medicants | |
EP1861057B1 (en) | Delivery tube assembly for an applicator | |
US3690321A (en) | Catamenial device | |
US3566871A (en) | Hydrophilic medical sponge and method of using same | |
EP1890758B1 (en) | Dosage form cap for an applicator | |
EP1861058B1 (en) | Protective tube for a medicated tampon | |
US2771882A (en) | Hygienic insertion for women | |
US3091241A (en) | Vaginal tampon | |
EP1861056B1 (en) | Dosage cap assembly for an applicator | |
US3948257A (en) | Vulvar deodorant system | |
DE69620625D1 (de) | Galenische einzeldosierung zur lokalen hormontherapie der vaginalen trockenheit | |
BR9815135A (pt) | "absorvente interno para a higiene feminina ou para finalidades médicas e processo para a produção do mesmo" | |
US3491759A (en) | Post-obstetrical catamenial pad | |
US20030120225A1 (en) | Therapeutic agent delivery labial pad | |
US4983163A (en) | Method, compositions and articles for prevention and treatment of herpes simplex virus infections | |
US2112021A (en) | Sanitary device | |
US2687729A (en) | Medical appliance | |
US3386441A (en) | Catamenial pad with an enzyme thereon | |
US1222825A (en) | Tampon or pessary. | |
IL30559A (en) | Tampon or similar sanitary napkin containing vitamin a | |
US3664341A (en) | Vaginal capsule | |
GB1228039A (enrdf_load_stackoverflow) | ||
JPH0157580B2 (enrdf_load_stackoverflow) |